Auxilium Pharma (NASDAQ: AUXL) had its target price cut by Canaccord Genuity from $33.00 to $27.00 in a report released on Wednesday. Canaccord Genuity currently has a buy rating on the stock.
Shares of Auxilium Pharma opened at 17.05 on Wednesday. Auxilium Pharma has a one year low of $16.25 and a one year high of $29.37. The stock’s 50-day moving average is currently $17.94. The company has a market cap of $838.0 million and a P/E ratio of 9.80.
AUXL has been the subject of a number of other recent research reports. Analysts at Bank of America cut their price target on shares of Auxilium Pharma to $25.00 in a research note to investors on Wednesday. Separately, analysts at Deutsche Bank cut their price target on shares of Auxilium Pharma from $22.00 to $21.00 in a research note to investors on Wednesday. They now have a buy rating on the stock. Finally, analysts at UBS AG raised their price target on shares of Auxilium Pharma from $50.00 to $52.00 in a research note to investors on Wednesday. They now have a buy rating on the stock.
Nine investment analysts have rated the stock with a buy rating, four have assigned a hold rating, and two have assigned a sell rating to the company. Auxilium Pharma has an average rating of overweight and an average price target of $23.58.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
